Adult Immunization Updates

Policy Shifts Affecting Recommendations

• 🔥 ACIP Membership Rules Revert: HHS withdrew the April ACIP charter revision that loosened membership...

A new model evaluated expanding age-based PCV recommendations from 65 to 50 using PCV20 or PCV21.

• Moving vaccination to age 50 reduced disease in...

HHS withdrew its April charter that loosened ACIP membership to allow experts in toxicology and data science, citing an administrative timing error. A...

Annual wellness visits provide a practical touchpoint to review adult vaccine status, as needs frequently shift with age and changing health conditions.

On June 18, 2026, the Vaccines and Related Biological Products Advisory Committee will meet to discuss and recommend on the safety and effectiveness of MFLUSIVA influenza vaccine.

Iowa now requires parental permission before children can receive vaccines against sexually transmitted diseases, including the HPV shot that the CDC...

No formal U.S. spring booster campaign exists, yet eligible adults should still consider vaccination this season if it’s been over six months since...

Older Adult Influenza Vaccination Insights

• 🔥 Community Center Preference: Older adults preferred receiving influenza vaccination at trusted...

Aligning flu vaccine services with older adult preferences can improve uptake and support equitable delivery.

• Trusted community health centres are...

WPA emphasizes life-course immunization to prevent non-communicable diseases through targeted adult vaccines.

• HPV vaccination prevents cervical...

Colorado passed a new law allowing health officials to follow national medical groups rather than federal guidance for vaccine decisions, including...

Health experts highly recommend the two-dose Shingrix series starting at age 50 to prevent painful viral reactivation affecting nerve endings. This positions your 50s as a critical decade for catching up on adult vaccines.

Older adults with prior-year flu shots, frequent primary care visits, and vaccinated spouses show markedly higher vaccination rates, while dementia...

Adult Influenza Vaccine Studies

• 🔥 Adjuvanted vs High-Dose Flu Vaccines: A Kaiser Permanente study found adjuvanted and high-dose influenza...

Pfizer's experimental 25vPnC pneumococcal vaccine generated significantly stronger immune responses than Prevnar 20 in a mid-stage infant study, with...

Researchers from Moderna have tested an mRNA-based influenza vaccine for older adults, a group currently recommended to receive adjuvanted, high-dose, or recombinant options. Watch for head-to-head efficacy data against these ACIP-preferred vaccines.

Erica Schwartz brings strong credentials and vaccine support to the CDC director role, offering a stabilizing influence on adult immunization...

Global adult immunization status has shifted notably since the COVID-19 pandemic, alongside continued tuberculosis vaccine progress that informs personal health choices abroad.

A large Kaiser Permanente study found adjuvanted and high-dose flu vaccines performed similarly against lab-confirmed influenza and serious outcomes...

ACIP Recommendation Updates

• 🔥 Shingles Vaccine Preference: ACIP now prefers RZV over ZVL and provides clinical guidance for use in special...